SCHEDULE: Khrom Capital Discloses 5.66% Stake in Acadia Healthcare

Khrom Capital Management and Eric Khrom have filed a Schedule 13G reporting a 5.66% beneficial ownership stake in Acadia Healthcare Company, Inc.

Summary

• Khrom Investments Fund, LP, Khrom Capital Management LLC, and Eric Khrom collectively report beneficial ownership of 5,201,533 shares of Acadia Healthcare common stock.
• This holding represents approximately 5.66% of the company's total outstanding shares, based on 91,967,027 shares outstanding as of April 28, 2026.
• The filing is a passive investment disclosure, indicating the shares were acquired in the ordinary course of business without the intent to change or influence company control.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory event, as it simply confirms existing institutional interest without signaling a change in corporate strategy or management.

Positives

• Institutional investor confidence is demonstrated by the accumulation of a significant 5.66% stake in the company.
• The investment is classified as passive, suggesting a long-term investment approach rather than an activist campaign.

Negatives

• None identified; this is a standard regulatory disclosure of beneficial ownership.

Risks

• Market volatility affecting the value of the 5.2 million shares held by the reporting persons.
• Potential for future changes in investment strategy if the reporting persons decide to shift from passive to active involvement.

Future Outlook

The filing does not provide specific forward-looking guidance, as it is a regulatory disclosure of ownership status.

Management Comments

• The reporting persons certify that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors in the healthcare sector, reflecting ongoing capital allocation trends in behavioral health services.

Comparison to Industry Standards

• The 5.66% stake is consistent with typical institutional holding patterns for mid-cap healthcare service providers.
• The passive nature of the filing aligns with standard investment practices for firms like Khrom Capital.

Legal Proceedings

• None disclosed.

Related Party Transactions

• The filing discloses that Khrom Capital Management LLC manages the accounts of Khrom Investments Fund, LP, and that Eric Khrom is the managing member of Khrom Capital.

Stakeholder Impact

• Shareholders may view the disclosure of a 5.66% stake by an institutional investor as a sign of market validation for the company's long-term prospects.

Next Steps

• The reporting persons are required to file amendments to this statement if there are material changes in the percentage of shares owned.

Key Dates

Keywords

Acadia Healthcare, Schedule 13G, Khrom Capital, Institutional Ownership, Healthcare Services, Beneficial Ownership